323 related articles for article (PubMed ID: 10408872)
1. Cytochrome P450 1A1 genetic polymorphisms and risk of hepatocellular carcinoma among chronic hepatitis B carriers.
Yu MW; Chiu YH; Yang SY; Santella RM; Chern HD; Liaw YF; Chen CJ
Br J Cancer; 1999 May; 80(3-4):598-603. PubMed ID: 10408872
[TBL] [Abstract][Full Text] [Related]
2. A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers.
Yu MW; Yang SY; Chiu YH; Chiang YC; Liaw YF; Chen CJ
Hepatology; 1999 Mar; 29(3):697-702. PubMed ID: 10051470
[TBL] [Abstract][Full Text] [Related]
3. Genetic Polymorphisms of Cytochrome P4501A1 (CYP1A1) and Glutathione S-Transferase P1 (GSTP1) and Risk of Hepatocellular Carcinoma Among Chronic Hepatitis C Patients in Egypt.
Abo-Hashem EM; El-Emshaty WM; Farag Rel S; Zakaria S; Abd El-Aziz M; Ghonaim A
Biochem Genet; 2016 Oct; 54(5):696-713. PubMed ID: 27271262
[TBL] [Abstract][Full Text] [Related]
4. Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma.
Chen CC; Yang SY; Liu CJ; Lin CL; Liaw YF; Lin SM; Lee SD; Chen PJ; Chen CJ; Yu MW
Int J Epidemiol; 2005 Dec; 34(6):1310-8. PubMed ID: 16172101
[TBL] [Abstract][Full Text] [Related]
5. Interaction between cytochrome P450 1A2 genetic polymorphism and cigarette smoking on the risk of hepatocellular carcinoma in a Japanese population.
Imaizumi T; Higaki Y; Hara M; Sakamoto T; Horita M; Mizuta T; Eguchi Y; Yasutake T; Ozaki I; Yamamoto K; Onohara S; Kawazoe S; Shigematsu H; Koizumi S; Kudo S; Tanaka K
Carcinogenesis; 2009 Oct; 30(10):1729-34. PubMed ID: 19643819
[TBL] [Abstract][Full Text] [Related]
6. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
[TBL] [Abstract][Full Text] [Related]
7. Role of N-acetyltransferase polymorphisms in hepatitis B related hepatocellular carcinoma: impact of smoking on risk.
Yu MW; Pai CI; Yang SY; Hsiao TJ; Chang HC; Lin SM; Liaw YF; Chen PJ; Chen CJ
Gut; 2000 Nov; 47(5):703-9. PubMed ID: 11034589
[TBL] [Abstract][Full Text] [Related]
8. CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer.
Silvestri L; Sonzogni L; De Silvestri A; Gritti C; Foti L; Zavaglia C; Leveri M; Cividini A; Mondelli MU; Civardi E; Silini EM
Int J Cancer; 2003 Apr; 104(3):310-7. PubMed ID: 12569554
[TBL] [Abstract][Full Text] [Related]
9. Association of polymorphism in microRNA 604 with susceptibility to persistent hepatitis B virus infection and development of hepatocellular carcinoma.
Cheong JY; Shin HD; Cho SW; Kim YJ
J Korean Med Sci; 2014 Nov; 29(11):1523-7. PubMed ID: 25408584
[TBL] [Abstract][Full Text] [Related]
10. A p53 polymorphism modifies the risk of hepatocellular carcinoma among non-carriers but not carriers of chronic hepatitis B virus infection.
Zhu ZZ; Cong WM; Liu SF; Xian ZH; Wu WQ; Wu MC; Gao B; Hou LF; Zhu GS
Cancer Lett; 2005 Nov; 229(1):77-83. PubMed ID: 15979781
[TBL] [Abstract][Full Text] [Related]
11. Interactions between CYP1A1 polymorphisms and cigarette smoking are associated with the risk of hepatocellular carcinoma: evidence from epidemiological studies.
Yu L; Sun L; Jiang YF; Lu BL; Sun DR; Zhu LY
Mol Biol Rep; 2012 Jun; 39(6):6641-6. PubMed ID: 22297691
[TBL] [Abstract][Full Text] [Related]
12. N-Acetyltransferase-2, glutathione S-transferase M1 and T1 genetic polymorphisms, cigarette smoking and hepatocellular carcinoma: a case-control study.
Gelatti U; Covolo L; Talamini R; Tagger A; Barbone F; Martelli C; Cremaschini F; Franceschi S; Ribero ML; Garte S; Nardi G; Donadon V; Donato F
Int J Cancer; 2005 Jun; 115(2):301-6. PubMed ID: 15688397
[TBL] [Abstract][Full Text] [Related]
13. Association between interleukin-21 gene polymorphisms (rs12508721) and HBV-related hepatocellular carcinoma.
Zhang QX; Li SL; Yao YQ; Li TJ
Int J Immunogenet; 2016 Jun; 43(3):151-8. PubMed ID: 27122304
[TBL] [Abstract][Full Text] [Related]
14. Common genetic variations of the cytochrome P450 1A1 gene and risk of hepatocellular carcinoma in a Chinese population.
Li R; Shugart YY; Zhou W; An Y; Yang Y; Zhou Y; Zhang B; Lu D; Wang H; Qian J; Jin L
Eur J Cancer; 2009 May; 45(7):1239-1247. PubMed ID: 19110417
[TBL] [Abstract][Full Text] [Related]
15. Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.
Han Y; Pu R; Han X; Zhao J; Li W; Yin J; Zhang Y; Shen Q; Xie J; Zhang Q; Jiang S; Li J; Zhang H; Wang H; Cao G
Liver Int; 2014 May; 34(5):728-36. PubMed ID: 24118778
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma and polymorphisms in carcinogen-metabolizing and DNA repair enzymes in a population with aflatoxin exposure and hepatitis B virus endemicity.
Kirk GD; Turner PC; Gong Y; Lesi OA; Mendy M; Goedert JJ; Hall AJ; Whittle H; Hainaut P; Montesano R; Wild CP
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):373-9. PubMed ID: 15734960
[TBL] [Abstract][Full Text] [Related]
17. Glutathione-S-transferase and microsomal epoxide hydrolase polymorphism and viral-related hepatocellular carcinoma risk in India.
Kiran M; Chawla YK; Kaur J
DNA Cell Biol; 2008 Dec; 27(12):687-94. PubMed ID: 18816171
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor alpha polymorphisms associated with susceptibility to hepatocellular carcinoma in hepatitis B virus carriers.
Zhai Y; Zhou G; Deng G; Xie W; Dong X; Zhang X; Yu L; Yang H; Yuan X; Zhang H; Zhi L; Yao Z; Shen Y; Qiang B; He F
Gastroenterology; 2006 Jun; 130(7):2001-9. PubMed ID: 16762623
[TBL] [Abstract][Full Text] [Related]
19. Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection--association between TGF-beta1 polymorphisms and hepatocellular carcinoma.
Migita K; Miyazoe S; Maeda Y; Daikoku M; Abiru S; Ueki T; Yano K; Nagaoka S; Matsumoto T; Nakao K; Hamasaki K; Yatsuhashi H; Ishibashi H; Eguchi K
J Hepatol; 2005 Apr; 42(4):505-10. PubMed ID: 15763337
[TBL] [Abstract][Full Text] [Related]
20. Association of HLA-DRB1*13 and TNF-alpha gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population.
Kummee P; Tangkijvanich P; Poovorawan Y; Hirankarn N
J Viral Hepat; 2007 Dec; 14(12):841-8. PubMed ID: 18070287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]